Continuous infusion of vancomycin in neonates

被引：26
|
作者：
Patel, Anisa D. [1 ,2 ]
Anand, Dhullipala [1 ]
Lucas, Carol [3 ]
Thomson, Alison H. [4 ,5 ]
机构：
[1] Royal Hosp Sick Children, Neonatal Intens Care Unit, Glasgow G3 8SJ, Lanark, Scotland
[2] Royal Hosp Sick Children, Yorkhill Hosp, Dept Pharm, Glasgow G3 8SJ, Lanark, Scotland
[3] Royal Hosp Sick Children, Dept Clin Microbiol, Glasgow G3 8SJ, Lanark, Scotland
[4] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[5] Western Infirm & Associated Hosp, Dept Pharm, Glasgow, Lanark, Scotland
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2013年 / 98卷 / 06期
关键词：
D O I：
10.1136/archdischild-2012-303197
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [21] Role of fluid status markers as risk factors for suboptimal vancomycin concentration during continuous infusion in neonates: an observational study
    V. L. Cousin
    Q. Laudouar
    N. Le Saché
    M. Mokhtari
    P. Durand
    V. Furlan
    P. Tissières
    European Journal of Pediatrics, 2022, 181 : 2935 - 2942
  • [22] CONTINUOUS INFUSION OF VANCOMYCIN IN SEPTIC PATIENTS ON CONTINUOUS RENAL REPLACEMENT THERAPY
    Covajes, C.
    De Backer, D.
    Ocampos-Martinez, E.
    Penaccini, L.
    Abdelhadi, A.
    Jacobs, F.
    Vincent, J. -L.
    Taccone, F. S.
    INTENSIVE CARE MEDICINE, 2011, 37 : S264 - S264
  • [23] Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented gram positive infections: A new dosage schedule
    Plan, O
    Milesi, C
    Pidoux, O
    Fournier-Favre, S
    Badr, M
    Mazurier, E
    Montoya, F
    Picard, JC
    PEDIATRIC RESEARCH, 2004, 55 (04) : 398A - 398A
  • [24] Role of fluid status markers as risk factors for suboptimal vancomycin concentration during continuous infusion in neonates: an observational study
    Cousin, V. L.
    Laudouar, Q.
    Le Sache, N.
    Mokhtari, M.
    Durand, P.
    Furlan, V
    Tissieres, P.
    EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (08) : 2935 - 2942
  • [25] VANCOMYCIN CONTINUOUS VERSUS INTERMITTENT INFUSION DURING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Lin, Hsin
    Bukovskaya, Yana
    de Moya, Marc
    Schmidt, Ulrich
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [26] Continuous infusion of vancomycin:: Are we using the right dose?
    Conceiçao, MF
    Paiva, JA
    Pereira, JM
    Aguiar, L
    Barbosa, S
    Gomes, JP
    Honrado, T
    Maia, I
    Massada, S
    Rios, M
    Sousa-Dias, C
    Mota, AM
    INTENSIVE CARE MEDICINE, 2001, 27 : S171 - S171
  • [27] NEPHROTOXICITY DURING CONTINUOUS INFUSION OF VANCOMYCIN IN SEPTIC PATIENT
    Cianferroni, S.
    Devigili, A.
    Hougardy, J. -M.
    Penaccini, L.
    Ocampos-Martinez, E.
    Abdelhadii, A.
    Jacobs, F.
    Vincent, J. -L.
    Taccone, F. S.
    INTENSIVE CARE MEDICINE, 2010, 36 : S247 - S247
  • [28] Optimising vancomycin doses in continuous infusion for septic patients
    Taccone, Fabio Silvio
    Jacobs, Frederique
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (04) : 385 - 385
  • [29] CONTINUOUS-INFUSION OF VANCOMYCIN IN NEWBORN-INFANTS
    BORDERON, JC
    LAUGIER, J
    CHAMBOUX, C
    SALIBA, E
    MATHIEU, A
    PATHOLOGIE BIOLOGIE, 1994, 42 (05): : 525 - 529
  • [30] Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
    Derijks-Engwegen, Judith Y. M. N.
    Jager, Nynke G. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 665 - 669
12345